Solid Biosciences Inc(NASDAQ:SLDB) 
Solid Biosciences Inc., a life science company, engages in developing therapies for duchenne muscular dystrophy (DMD) in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expre...
Website: http://www.solidbio.com
Founded: 2013
Full Time Employees: 121
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating expenses: | ||||||||||||||||||||||||||||||||||
research and development | 46,140,000 | 38,135,000 | 38,861,000 | 32,415,000 | 30,914,000 | 30,770,000 | 27,327,000 | 19,461,000 | 18,873,000 | 15,453,000 | 16,702,000 | 19,777,000 | 24,631,000 | 21,290,000 | 14,005,000 | 23,180,000 | 19,945,000 | 14,595,000 | 14,425,000 | 15,513,000 | 14,206,000 | 15,723,000 | 16,045,000 | 13,448,000 | 19,665,000 | 27,066,000 | 22,792,000 | 21,610,000 | 23,269,000 | 17,762,000 | 14,680,000 | 13,594,000 | 11,929,000 | |
general and administrative | 11,168,000 | 11,268,000 | 9,197,000 | 9,278,000 | 9,138,000 | 9,126,000 | 7,855,000 | 8,327,000 | 7,989,000 | 6,812,000 | 6,412,000 | 7,129,000 | 7,399,000 | 7,618,000 | 7,127,000 | 6,851,000 | 7,352,000 | 7,211,000 | 7,143,000 | 6,766,000 | 6,015,000 | 5,624,000 | 5,181,000 | 5,526,000 | 5,250,000 | 5,264,000 | 6,925,000 | 5,359,000 | 7,033,000 | 4,624,000 | 4,470,000 | 4,584,000 | 4,044,000 | |
total operating expenses | 57,308,000 | 49,403,000 | 48,058,000 | 41,693,000 | 40,052,000 | 39,896,000 | 35,182,000 | 27,788,000 | 26,862,000 | 22,265,000 | 23,114,000 | 26,843,000 | 32,030,000 | 34,566,000 | 21,132,000 | 31,551,000 | 27,297,000 | 21,806,000 | 21,568,000 | 22,279,000 | 20,221,000 | 21,347,000 | 21,226,000 | 18,974,000 | 26,859,000 | 32,330,000 | 29,717,000 | 26,969,000 | 30,302,000 | 22,386,000 | 19,150,000 | 18,178,000 | 15,973,000 | |
income from operations | -57,308,000 | -49,403,000 | -48,058,000 | -41,693,000 | -40,052,000 | -39,896,000 | -35,182,000 | -27,788,000 | -26,862,000 | -22,265,000 | -23,114,000 | -26,843,000 | -32,030,000 | -34,566,000 | -21,132,000 | -25,382,000 | -25,372,000 | -18,652,000 | -18,031,000 | -18,685,000 | -16,886,000 | -21,347,000 | -21,226,000 | -18,974,000 | -26,859,000 | -32,330,000 | -29,717,000 | -26,969,000 | -30,302,000 | -22,386,000 | -19,150,000 | -18,178,000 | -15,973,000 | |
yoy | 43.08% | 23.83% | 36.60% | 50.04% | 49.10% | 79.19% | 52.21% | 3.52% | -16.13% | -35.59% | 9.38% | 5.76% | 26.24% | 85.32% | 17.20% | 35.84% | 50.25% | -12.62% | -15.05% | -1.52% | -37.13% | -33.97% | -28.57% | -29.65% | -11.36% | 44.42% | 55.18% | 48.36% | 89.71% | |||||
qoq | 16.00% | 2.80% | 15.27% | 4.10% | 0.39% | 13.40% | 26.61% | 3.45% | 20.65% | -3.67% | -13.89% | -16.19% | -7.34% | 63.57% | -16.74% | 0.04% | 36.03% | 3.44% | -3.50% | 10.65% | -20.90% | 0.57% | 11.87% | -29.36% | -16.92% | 8.79% | 10.19% | -11.00% | 35.36% | 16.90% | 5.35% | 13.80% | ||
operating margin % | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | NaN% | NaN% | NaN% | -Infinity% | NaN% | NaN% | NaN% | -Infinity% | NaN% | NaN% | NaN% | |
other income, net: | ||||||||||||||||||||||||||||||||||
interest income | 2,064,000 | 2,052,000 | 2,586,000 | 2,966,000 | 2,300,000 | 1,925,000 | 2,328,000 | 2,565,000 | 2,651,000 | 1,659,000 | 1,856,000 | 1,949,000 | 1,678,000 | -13,000 | -14,000 | -16,000 | -20,000 | -13,000 | 164,000 | 299,000 | 406,000 | 367,000 | 508,000 | 382,000 | 92,000 | 80,000 | 65,000 | |||||||
interest expense | -5,000 | 336,000 | -60,000 | -68,000 | -75,000 | -82,000 | -88,000 | -95,000 | ||||||||||||||||||||||||||
change in fair value of derivative liabilities | -1,650,000 | -2,650,000 | -850,000 | -900,000 | -1,650,000 | |||||||||||||||||||||||||||||
other income | 157,000 | 219,000 | 210,000 | 207,000 | 188,000 | 199,000 | 211,000 | 239,000 | 3,000 | 270,000 | 278,000 | 265,000 | 282,000 | -1,437,000 | 722,000 | 290,000 | 44,000 | -22,000 | 48,000 | 3,000 | 1,000 | 170,000 | 56,000 | 77,000 | 212,000 | 83,000 | 38,000 | 118,000 | 31,000 | |||||
total other income | 571,000 | -384,000 | 2,282,000 | 2,213,000 | 770,000 | -2,701,000 | 2,457,000 | 2,716,000 | 2,559,000 | 1,929,000 | 2,134,000 | 2,214,000 | 1,960,000 | -10,000 | -14,000 | -16,000 | -20,000 | -13,000 | 165,000 | 469,000 | 462,000 | 444,000 | 720,000 | 465,000 | 130,000 | 198,000 | 96,000 | |||||||
net income | -56,737,000 | -49,787,000 | -45,776,000 | -39,480,000 | -39,282,000 | -42,597,000 | -32,725,000 | -25,072,000 | -24,303,000 | -20,336,000 | -20,980,000 | -24,629,000 | -30,070,000 | -15,151,000 | -20,410,000 | -25,092,000 | -25,328,000 | -18,610,000 | -17,983,000 | -18,695,000 | -16,900,000 | -21,363,000 | -21,246,000 | -18,987,000 | -26,694,000 | -31,861,000 | -29,255,000 | -26,525,000 | -29,582,000 | -21,921,000 | -19,020,000 | -17,980,000 | -15,877,000 | |
yoy | 44.44% | 16.88% | 39.88% | 57.47% | 61.63% | 109.47% | 55.98% | 1.80% | -19.18% | 34.22% | 2.79% | -1.85% | 18.72% | -18.59% | 13.50% | 34.22% | 49.87% | -12.89% | -15.36% | -1.54% | -36.69% | -32.95% | -27.38% | -28.42% | -9.76% | 45.34% | 53.81% | 47.53% | 86.32% | |||||
qoq | 13.96% | 8.76% | 15.95% | 0.50% | -7.78% | 30.17% | 30.52% | 3.16% | 19.51% | -3.07% | -14.82% | -18.09% | 98.47% | -25.77% | -18.66% | -0.93% | 36.10% | 3.49% | -3.81% | 10.62% | -20.89% | 0.55% | 11.90% | -28.87% | -16.22% | 8.91% | 10.29% | -10.33% | 34.95% | 15.25% | 5.78% | 13.25% | ||
net income margin % | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | -Infinity% | NaN% | NaN% | NaN% | -Infinity% | NaN% | NaN% | NaN% | -Infinity% | NaN% | NaN% | NaN% | |
net income per share | -0.52 | -0.53 | -0.48 | -0.42 | -0.59 | -1.02 | -0.79 | -0.61 | -0.64 | -1 | -1.05 | -1.25 | -1.54 | -0.68 | -2.71 | -0.22 | -0.22 | -0.17 | -0.16 | -0.17 | -0.19 | -0.31 | -0.44 | -0.39 | -0.56 | -0.65 | -0.67 | -0.76 | -0.85 | -0.64 | -0.55 | -0.52 | -0.54 | |
weighted-average shares of common stock outstanding, used to compute basic and diluted net loss per share | 109,811,461 | 94,417,746 | 94,140,286 | 66,341,305 | ||||||||||||||||||||||||||||||
restructuring charges | -15,750 | -63,000 | 380,000 | 1,520,000 | 486,000 | 1,944,000 | ||||||||||||||||||||||||||||
weighted-average shares of common stock outstanding, basic and diluted | 41,443,317 | 40,934,361 | 38,155,373 | 20,059,641 | 19,663,672 | 19,567,635 | 7,532,706 | 112,859,461 | 112,607,322 | 112,312,970 | 112,298,982 | 89,267,194 | 48,295,468 | 48,163,094 | 48,059,279 | 43,467,618 | 34,843,344 | 34,776,488 | 34,539,001 | 34,449,758 | 29,354,650 | |||||||||||||
collaboration revenue - related party | 2,023,500 | 6,169,000 | 1,925,000 | 2,616,500 | 3,537,000 | 3,594,000 | 3,335,000 | |||||||||||||||||||||||||||
other income: | ||||||||||||||||||||||||||||||||||
revenue | ||||||||||||||||||||||||||||||||||
yoy | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | ||||||||||||||||||||||||||||
qoq | NaN% | NaN% | NaN% | NaN% | NaN% | NaN% | ||||||||||||||||||||||||||||
revaluation of preferred unit tranche rights | ||||||||||||||||||||||||||||||||||
net loss attributable to non-controlling interest | ||||||||||||||||||||||||||||||||||
net loss attributable to solid biosciences inc. | -21,921,000 | -19,020,000 | -17,980,000 | -15,877,000 | ||||||||||||||||||||||||||||||
accretion of preferred units to redemption value | ||||||||||||||||||||||||||||||||||
redemption of preferred units | ||||||||||||||||||||||||||||||||||
redemption of redeemable interest from non-controlling interest in solid gt | ||||||||||||||||||||||||||||||||||
net loss attributable to common stockholders | -21,921,000 | -19,020,000 | -17,980,000 | -15,877,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||||||
current assets: | |||||||||||||||||||||||||||||||||
cash and cash equivalents | 297,099,000 | 59,900,000 | 61,364,000 | 138,933,000 | 210,629,000 | 80,235,000 | 64,394,000 | 95,854,000 | 117,574,000 | 74,015,000 | 49,037,000 | 91,569,000 | 164,649,000 | 155,384,000 | 48,790,000 | 54,311,000 | 129,711,000 | 119,136,000 | 109,676,000 | 200,609,000 | 268,497,000 | 154,744,000 | 24,797,000 | 40,441,000 | 53,187,000 | 76,043,000 | 94,720,000 | 51,836,000 | 53,994,000 | 86,366,000 | 129,137,000 | 145,824,000 | 164,773,000 |
available-for-sale securities | 83,581,000 | 127,950,000 | 174,778,000 | 129,177,000 | 96,289,000 | 68,685,000 | 106,723,000 | 94,412,000 | 88,492,000 | 49,625,000 | 93,847,000 | 68,623,000 | 20,860,000 | 58,338,000 | 93,367,000 | 108,572,000 | 50,339,000 | 88,643,000 | 120,084,000 | 48,350,000 | 7,481,000 | 36,098,000 | |||||||||||
prepaid expenses and other current assets | 15,470,000 | 16,384,000 | 8,710,000 | 10,530,000 | 6,491,000 | 8,382,000 | 8,377,000 | 7,344,000 | 8,126,000 | 6,094,000 | 5,462,000 | 7,283,000 | 5,095,000 | 5,916,000 | 5,115,000 | 7,319,000 | 18,544,000 | 14,723,000 | 8,366,000 | 5,743,000 | 5,518,000 | 4,157,000 | 2,365,000 | 3,094,000 | 4,316,000 | 2,778,000 | 7,829,000 | 10,935,000 | 7,043,000 | 6,175,000 | 3,062,000 | 1,714,000 | 1,931,000 |
restricted cash, current | 638,000 | 1,222,000 | 237,000 | 237,000 | 90,000 | 90,000 | |||||||||||||||||||||||||||
total current assets | 396,788,000 | 205,456,000 | 244,852,000 | 278,640,000 | 313,409,000 | 157,302,000 | 179,494,000 | 197,610,000 | 214,192,000 | 129,734,000 | 148,346,000 | 167,475,000 | 190,604,000 | 219,638,000 | 147,509,000 | 170,439,000 | 198,608,000 | 222,612,000 | 238,810,000 | 255,078,000 | 274,295,000 | 158,901,000 | 27,162,000 | 43,535,000 | 57,903,000 | 86,302,000 | 113,492,000 | 78,321,000 | 101,787,000 | 128,639,000 | 148,431,000 | 164,473,000 | 184,378,000 |
non-current assets: | |||||||||||||||||||||||||||||||||
operating lease, right-of-use assets | 21,300,000 | 21,924,000 | 22,535,000 | 23,133,000 | 23,720,000 | 24,859,000 | 25,508,000 | 26,098,000 | 27,189,000 | 27,841,000 | 28,306,000 | 28,444,000 | 28,939,000 | 722,000 | 1,218,000 | 1,581,000 | 3,196,000 | 3,951,000 | 4,310,000 | 4,655,000 | 5,529,000 | 5,618,000 | 5,916,000 | ||||||||||
property and equipment | 3,914,000 | 4,169,000 | 4,356,000 | 4,317,000 | 4,483,000 | 4,747,000 | 5,067,000 | 5,438,000 | 6,391,000 | 6,624,000 | 7,045,000 | 7,391,000 | 8,607,000 | 9,657,000 | 6,266,000 | 6,847,000 | 6,097,000 | 6,462,000 | 6,886,000 | 7,128,000 | 7,461,000 | 8,153,000 | 8,869,000 | 9,582,000 | 10,866,000 | 11,645,000 | 11,369,000 | 11,829,000 | 11,995,000 | 10,422,000 | 7,935,000 | 6,551,000 | 4,418,000 |
other non-current assets | 183,000 | 223,000 | 247,000 | 278,000 | 319,000 | 366,000 | 475,000 | 515,000 | 175,000 | 209,000 | 315,000 | 181,000 | 238,000 | 175,000 | 422,000 | 438,000 | 59,000 | 94,000 | 209,000 | 209,000 | 209,000 | 209,000 | 209,000 | 209,000 | 209,000 | 209,000 | 209,000 | 209,000 | 209,000 | 209,000 | |||
restricted cash, net of current portion | 708,000 | 768,000 | |||||||||||||||||||||||||||||||
total non-current assets | 26,105,000 | 27,084,000 | 29,062,000 | 29,652,000 | 30,495,000 | 31,360,000 | 32,332,000 | 33,371,000 | |||||||||||||||||||||||||
total assets | 422,893,000 | 232,540,000 | 273,914,000 | 308,292,000 | 343,904,000 | 188,662,000 | 211,826,000 | 230,981,000 | 248,689,000 | 164,939,000 | 184,728,000 | 204,721,000 | 229,588,000 | 260,252,000 | 184,474,000 | 208,496,000 | 207,556,000 | 232,380,000 | 248,986,000 | 265,857,000 | 285,279,000 | 171,169,000 | 40,518,000 | 57,963,000 | 73,960,000 | 103,471,000 | 130,926,000 | 96,304,000 | 120,234,000 | 139,597,000 | 156,812,000 | 171,470,000 | 189,242,000 |
liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||
current liabilities: | |||||||||||||||||||||||||||||||||
accounts payable | 5,563,000 | 3,224,000 | 8,429,000 | 4,704,000 | 6,439,000 | 4,237,000 | 3,458,000 | 2,521,000 | 1,730,000 | 2,032,000 | 1,898,000 | 2,968,000 | 5,595,000 | 3,238,000 | 5,150,000 | 5,109,000 | 4,761,000 | 4,463,000 | 4,148,000 | 3,003,000 | 3,194,000 | 3,274,000 | 4,083,000 | 2,793,000 | 2,383,000 | 7,124,000 | 3,210,000 | 5,600,000 | 5,352,000 | 3,691,000 | 4,804,000 | 3,741,000 | 5,835,000 |
accrued expenses and other current liabilities | 19,182,000 | 18,945,000 | 19,050,000 | 16,546,000 | 14,576,000 | 19,852,000 | 13,227,000 | 9,918,000 | 7,409,000 | 5,833,000 | 4,938,000 | 4,092,000 | |||||||||||||||||||||
operating lease liabilities, current | 2,188,000 | 2,103,000 | |||||||||||||||||||||||||||||||
derivative liabilities | 3,350,000 | 9,200,000 | 6,550,000 | 5,700,000 | 4,800,000 | 3,150,000 | 3,400,000 | ||||||||||||||||||||||||||
total current liabilities | 30,283,000 | 33,472,000 | 36,342,000 | 29,846,000 | 28,779,000 | 30,257,000 | 22,854,000 | 14,688,000 | 14,339,000 | 14,517,000 | 15,816,000 | 15,866,000 | 20,293,000 | 22,508,000 | 16,925,000 | 21,718,000 | 21,744,000 | 23,601,000 | 22,542,000 | 22,545,000 | 22,829,000 | 24,480,000 | 14,765,000 | 13,168,000 | 12,880,000 | 18,276,000 | 16,750,000 | 13,671,000 | 14,572,000 | 12,481,000 | 10,637,000 | 8,679,000 | 9,927,000 |
non-current liabilities: | |||||||||||||||||||||||||||||||||
operating lease liabilities, net of current portion | 18,478,000 | 19,058,000 | 21,159,000 | ||||||||||||||||||||||||||||||
total non-current liabilities | 18,478,000 | 19,058,000 | 19,624,000 | 20,155,000 | 20,662,000 | 21,159,000 | 21,950,000 | 23,048,000 | |||||||||||||||||||||||||
total liabilities | 48,761,000 | 52,530,000 | 55,966,000 | 50,001,000 | 49,441,000 | 51,416,000 | 44,804,000 | 37,736,000 | 37,965,000 | 38,458,000 | 40,367,000 | 40,993,000 | 45,801,000 | 48,586,000 | 41,199,000 | 46,261,000 | 22,045,000 | 24,169,000 | 25,623,000 | 27,919,000 | 32,279,000 | 39,083,000 | 18,287,000 | 17,250,000 | 17,504,000 | 23,423,000 | 22,401,000 | 19,809,000 | 21,121,000 | 14,414,000 | 11,739,000 | 9,178,000 | 10,292,000 |
commitments and contingencies | |||||||||||||||||||||||||||||||||
stockholders' equity: | |||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value... | |||||||||||||||||||||||||||||||||
common stock, 0.001 par value... | 98,000 | 79,000 | 40,000 | 20,000 | 20,000 | 20,000 | 20,000 | 20,000 | 8,000 | 112,000 | 112,000 | 112,000 | 112,000 | 112,000 | 112,000 | 87,000 | 48,000 | 48,000 | 48,000 | 48,000 | 48,000 | 35,000 | 35,000 | 35,000 | 35,000 | 35,000 | 35,000 | ||||||
additional paid-in capital | 1,388,559,000 | 1,137,654,000 | 1,125,810,000 | 1,120,463,000 | 1,117,116,000 | 920,609,000 | 907,720,000 | 901,349,000 | 893,746,000 | 785,199,000 | 782,756,000 | 781,131,000 | 776,570,000 | 774,452,000 | 691,050,000 | 689,422,000 | 687,535,000 | 684,901,000 | 681,420,000 | 678,001,000 | 674,357,000 | 536,568,000 | 405,389,000 | 402,625,000 | 399,382,000 | 396,278,000 | 392,897,000 | 331,620,000 | 327,709,000 | 324,209,000 | 322,179,000 | 320,382,000 | 319,073,000 |
accumulated other comprehensive income | -13,000 | 52,000 | 48,000 | -38,000 | 2,000 | 47,000 | 116,000 | -15,000 | -4,000 | 15,000 | 2,000 | 14,000 | 5,000 | ||||||||||||||||||||
accumulated deficit | -1,014,512,000 | -957,775,000 | -907,988,000 | -862,212,000 | -822,732,000 | -783,450,000 | -740,853,000 | -708,128,000 | -683,056,000 | -658,753,000 | -638,417,000 | -617,437,000 | -592,808,000 | -562,738,000 | -547,587,000 | -527,177,000 | -502,085,000 | -476,757,000 | -458,147,000 | -440,164,000 | -421,469,000 | -404,569,000 | -383,206,000 | -361,960,000 | -342,973,000 | -316,279,000 | -284,418,000 | -255,163,000 | -228,638,000 | -199,056,000 | -177,135,000 | -158,115,000 | -140,135,000 |
total stockholders’ equity | 374,132,000 | 180,010,000 | 217,948,000 | 258,291,000 | 294,463,000 | 167,022,000 | 193,245,000 | 210,724,000 | 144,361,000 | 163,728,000 | 183,787,000 | 143,275,000 | 162,235,000 | 185,511,000 | 223,363,000 | 237,938,000 | 253,000,000 | 22,231,000 | 40,713,000 | 56,456,000 | 108,525,000 | 76,495,000 | 99,113,000 | ||||||||||
total liabilities and stockholders’ equity | 422,893,000 | 232,540,000 | 273,914,000 | 308,292,000 | 343,904,000 | 211,826,000 | 230,981,000 | 248,689,000 | 184,728,000 | 204,721,000 | 229,588,000 | 184,474,000 | 208,496,000 | 207,556,000 | 248,986,000 | 265,857,000 | 285,279,000 | 40,518,000 | 57,963,000 | 73,960,000 | 130,926,000 | 96,304,000 | 120,234,000 | ||||||||||
finance lease liabilities | 281,000 | 953,000 | 1,096,000 | 1,231,000 | 1,051,000 | 525,000 | 496,000 | 469,000 | 353,000 | 412,000 | 239,000 | 232,000 | 226,000 | 220,000 | 214,000 | 208,000 | 202,000 | 197,000 | 191,000 | 186,000 | 181,000 | 176,000 | 178,000 | ||||||||||
stockholders’ equity: | |||||||||||||||||||||||||||||||||
restricted cash | 1,924,000 | 1,924,000 | 1,973,000 | 1,952,000 | 1,931,000 | 1,910,000 | 1,833,000 | 1,833,000 | 1,833,000 | 1,833,000 | 1,833,000 | 1,833,000 | 1,833,000 | 1,833,000 | 2,070,000 | 2,070,000 | 327,000 | 327,000 | 327,000 | 327,000 | 327,000 | 327,000 | 327,000 | 327,000 | 327,000 | 65,000 | |||||||
operating lease liabilities | 2,032,000 | 1,943,000 | 1,868,000 | 1,787,000 | 1,718,000 | 1,724,000 | 1,694,000 | 1,855,000 | 1,847,000 | 1,853,000 | 1,863,000 | 1,897,000 | 1,062,000 | 33,000 | 984,000 | 1,263,000 | 1,227,000 | 1,499,000 | 1,965,000 | 1,999,000 | 1,930,000 | 1,863,000 | 1,799,000 | 1,736,000 | 1,672,000 | 1,610,000 | 1,278,000 | ||||||
operating lease liabilities, excluding current portion | 19,624,000 | 20,155,000 | 20,662,000 | 21,643,000 | 22,095,000 | 22,526,000 | 22,707,000 | 23,189,000 | 23,645,000 | 23,912,000 | 24,279,000 | 24,274,000 | 24,543,000 | 70,000 | 275,000 | 468,000 | 656,000 | 1,980,000 | 2,419,000 | 2,943,000 | 3,450,000 | 3,941,000 | 4,414,000 | 4,869,000 | 5,309,000 | 5,736,000 | |||||||
preferred stock, 0.001 par value — 10,000,000 shares authorized; no shares issued or outstanding at september 30, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||
common stock | 78,000 | 78,000 | 77,000 | 39,000 | 39,000 | 38,000 | |||||||||||||||||||||||||||
preferred stock, 0.001 par value — 10,000,000 shares authorized; no shares issued or outstanding at june 30, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value — 10,000,000 shares authorized; no shares issued or outstanding at march 31, 2025 and december 31, 2024 | |||||||||||||||||||||||||||||||||
operating lease, right-of-use asset | 24,295,000 | 26,539,000 | 28,949,000 | ||||||||||||||||||||||||||||||
liabilities and stockholders' equity | |||||||||||||||||||||||||||||||||
finance lease obligations, net of current portion | |||||||||||||||||||||||||||||||||
total stockholders' equity | 137,246,000 | 126,481,000 | 211,666,000 | 208,211,000 | 132,086,000 | 80,048,000 | |||||||||||||||||||||||||||
total liabilities and stockholders' equity | 188,662,000 | 164,939,000 | 260,252,000 | 232,380,000 | 171,169,000 | 103,471,000 | |||||||||||||||||||||||||||
finance lease liabilities, excluding current portion | 307,000 | 953,000 | 1,100,000 | 231,000 | 353,000 | 412,000 | 469,000 | 579,000 | 632,000 | 683,000 | 782,000 | 829,000 | 813,000 | ||||||||||||||||||||
preferred stock, 0.001 par value — 10,000,000 shares authorized; no shares issued and outstanding at september 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value — 10,000,000 shares authorized; no shares issued and outstanding at june 30, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||
accrued expenses | 10,327,000 | 10,137,000 | 11,466,000 | 10,509,000 | 12,384,000 | 16,691,000 | 10,275,000 | 16,141,000 | 9,440,000 | 9,528,000 | 8,003,000 | 7,714,000 | 6,794,000 | 8,640,000 | 8,550,000 | 8,315,000 | 8,507,000 | 9,178,000 | 11,466,000 | 6,007,000 | 8,235,000 | ||||||||||||
other current liabilities | 92,000 | 24,000 | 162,000 | 117,000 | 55,000 | 14,000 | 85,000 | 23,000 | 150,000 | 35,000 | 73,000 | 61,000 | 52,000 | 221,000 | 278,000 | 355,000 | 382,000 | ||||||||||||||||
preferred stock, 0.001 par value — 10,000,000 shares authorized; no shares issued and outstanding at march 31, 2024 and december 31, 2023 | |||||||||||||||||||||||||||||||||
finance lease obligations, excluding current portion | 1,234,000 | 293,000 | 525,000 | 733,000 | |||||||||||||||||||||||||||||
other non-current liabilities | 96,000 | 1,300,000 | 1,074,000 | 1,102,000 | 499,000 | 365,000 | |||||||||||||||||||||||||||
finance liabilities and finance lease liabilities | 443,000 | 419,000 | 396,000 | 668,000 | |||||||||||||||||||||||||||||
finance liabilities and finance lease liabilities, excluding current portion | 1,362,000 | 1,482,000 | 1,596,000 | ||||||||||||||||||||||||||||||
accounts receivable - related party | 14,000 | 110,000 | 594,000 | 286,000 | 280,000 | ||||||||||||||||||||||||||||
deferred revenue - related party | 6,170,000 | 8,080,000 | 8,865,000 | 10,048,000 | 10,662,000 | 10,359,000 | |||||||||||||||||||||||||||
finance liabilities and finance lease obligations, excluding current portion | 1,703,000 | ||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -68,000 | -196,000 | -122,000 | -51,000 | -45,000 | -22,000 | -11,000 | -2,000 | -5,000 | -6,000 | -10,000 | -23,000 | |||||||||||||||||||||
operating lease, right of use asset | 1,142,000 | 3,579,000 | 4,988,000 | ||||||||||||||||||||||||||||||
deferred revenue - related party, excluding current portion | 2,260,000 | 4,306,000 | 7,001,000 | 10,359,000 | |||||||||||||||||||||||||||||
restricted cash, excluding current portion | 2,072,000 | 2,070,000 | 327,000 | ||||||||||||||||||||||||||||||
accumulated other comprehensive gain | -1,000 | 1,000 | 3,000 | 7,000 | |||||||||||||||||||||||||||||
available-for-sale-securities | 400,000 | 10,943,000 | 15,550,000 | 40,750,000 | 16,232,000 | 16,935,000 | 17,609,000 | ||||||||||||||||||||||||||
deferred offering costs | |||||||||||||||||||||||||||||||||
liabilities, preferred units and stockholders' / members' equity / | |||||||||||||||||||||||||||||||||
current portion of capital lease obligations | 173,000 | ||||||||||||||||||||||||||||||||
capital lease obligations, net of current portion | 859,000 | ||||||||||||||||||||||||||||||||
series 2 senior preferred units, no units authorized at december 31, 2018 and 4,886,000 units authorized at december 31, 2017; no units issued and outstanding at december 31, 2018 and 4,886,000 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
series 1 senior preferred units, no units authorized at december 31, 2018 and 2,500,000 units authorized at december 31, 2017; no units issued and outstanding at december 31, 2018 and 2,500,000 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
junior preferred units, no units authorized at december 31, 2018 and 4,414,356 units authorized at december 31, 2017; no units issued and outstanding at december 31, 2018 and 4,414,356 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
stockholders’ / members’ equity / | |||||||||||||||||||||||||||||||||
series a, b, c and d common units, no units authorized at december 31, 2018 and 20,189,509 units authorized at december 31, 2017; no units issued and outstanding at december 31, 2018 and 19,438,552 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
total stockholders'/members’ equity/ | 125,183,000 | ||||||||||||||||||||||||||||||||
total liabilities, preferred units and stockholders'/members’ equity | 139,597,000 | ||||||||||||||||||||||||||||||||
liabilities, preferred units and stockholders’ / members’ equity / | |||||||||||||||||||||||||||||||||
series 2 senior preferred units, no units authorized at september 30, 2018 and 4,886,000 units authorized at december 31, 2017; no units issued and outstanding at september 30, 2018 and 4,886,000 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
series 1 senior preferred units, no units authorized at september 30, 2018 and 2,500,000 units authorized at december 31, 2017; no units issued and outstanding at september 30, 2018 and 2,500,000 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
junior preferred units, no units authorized at september 30, 2018 and 4,414,356 units authorized at december 31, 2017; no units issued and outstanding at september 30, 2018 and 4,414,356 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
series a, b, c and d common units, no units authorized at september 30, 2018 and 20,189,509 units authorized at december 31, 2017; no units issued and outstanding at september 30, 2018 and 19,438,552 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
total stockholders’/members’ equity/ | 145,073,000 | 162,292,000 | 178,950,000 | ||||||||||||||||||||||||||||||
total liabilities, preferred units and stockholders’/members’ equity | 156,812,000 | 171,470,000 | 189,242,000 | ||||||||||||||||||||||||||||||
revenue | |||||||||||||||||||||||||||||||||
operating expenses: | |||||||||||||||||||||||||||||||||
research and development | 14,680,000 | 13,594,000 | 11,929,000 | ||||||||||||||||||||||||||||||
general and administrative | 4,470,000 | 4,584,000 | 4,044,000 | ||||||||||||||||||||||||||||||
total operating expenses | 19,150,000 | 18,178,000 | 15,973,000 | ||||||||||||||||||||||||||||||
income from operations | -19,150,000 | -18,178,000 | -15,973,000 | ||||||||||||||||||||||||||||||
other income: | |||||||||||||||||||||||||||||||||
revaluation of preferred unit tranche rights | |||||||||||||||||||||||||||||||||
interest income | 92,000 | 80,000 | 65,000 | ||||||||||||||||||||||||||||||
other income | 38,000 | 118,000 | 31,000 | ||||||||||||||||||||||||||||||
total other income | 130,000 | 198,000 | 96,000 | ||||||||||||||||||||||||||||||
net income | -19,020,000 | -17,980,000 | -15,877,000 | ||||||||||||||||||||||||||||||
net income attributable to non-controlling interest | |||||||||||||||||||||||||||||||||
net income attributable to solid biosciences inc. | -19,020,000 | -17,980,000 | -15,877,000 | ||||||||||||||||||||||||||||||
accretion of preferred units to redemption value | |||||||||||||||||||||||||||||||||
redemption of preferred units | |||||||||||||||||||||||||||||||||
redemption of redeemable interest from non-controlling interest in solid gt | |||||||||||||||||||||||||||||||||
net income attributable to common stockholders | -19,020,000 | -17,980,000 | -15,877,000 | ||||||||||||||||||||||||||||||
net income per share | -550 | -520 | -540 | ||||||||||||||||||||||||||||||
weighted-average shares of common stock outstanding, basic and diluted | 34,539,001,000 | 34,449,758,000 | 29,354,650,000 | ||||||||||||||||||||||||||||||
series 2 senior preferred units, no units authorized at june 30, 2018 and 4,886,000 units authorized at december 31, 2017; no units issued and outstanding at june 30, 2018 and 4,886,000 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
series 1 senior preferred units, no units authorized at june 30, 2018 and 2,500,000 units authorized at december 31, 2017; no units issued and outstanding at june 30, 2018 and 2,500,000 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
junior preferred units, no units authorized at june 30, 2018 and 4,414,356 units authorized at december 31, 2017; no units issued and outstanding at june 30, 2018 and 4,414,356 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
series a, b, c and d common units, no units authorized at june 30, 2018 and 20,189,509 units authorized at december 31, 2017; no units issued and outstanding at june 30, 2018 and 19,438,552 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
series 2 senior preferred units, no units authorized at march 31, 2018 and 4,886,000 units authorized at december 31, 2017; no units issued and outstanding at march 31, 2018 and 4,886,000 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
series 1 senior preferred units, no units authorized at march 31, 2018 and 2,500,000 units authorized at december 31, 2017; no units issued and outstanding at march 31, 2018 and 2,500,000 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
junior preferred units, no units authorized at march 31, 2018 and 4,414,356 units authorized at december 31, 2017; no units issued and outstanding at march 31, 2018 and 4,414,356 units issued and outstanding at december 31, 2017 | |||||||||||||||||||||||||||||||||
series a, b, c and d common units, no units authorized at march 31, 2018 and 20,189,509 units authorized at december 31, 2017; no units issued and outstanding at march 31, 2018 and 19,438,552 units issued and outstanding at december 31, 2017 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | |||||||||||||||||||||||||||||||||
net loss | -56,737,000 | -49,787,000 | -45,776,000 | -39,480,000 | -39,282,000 | -42,597,000 | -32,725,000 | -25,072,000 | -24,303,000 | -20,336,000 | -20,980,000 | -24,629,000 | -30,070,000 | -15,151,000 | -20,410,000 | -25,092,000 | -25,328,000 | -18,610,000 | -17,983,000 | -18,695,000 | -16,900,000 | -21,363,000 | -21,246,000 | -18,987,000 | -26,694,000 | -31,861,000 | -29,255,000 | -26,525,000 | -29,582,000 | -21,921,000 | -19,020,000 | -17,980,000 | -15,877,000 |
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||||||||||||||
amortization of discount on available-for-sale securities | -619,000 | -747,000 | -327,000 | -488,000 | -312,000 | -1,208,000 | -1,041,000 | -540,000 | |||||||||||||||||||||||||
equity-based compensation expense | 5,152,000 | 6,500,000 | 3,928,000 | 3,145,000 | 3,341,000 | 3,821,000 | 2,995,000 | 2,092,000 | 1,611,000 | 1,938,000 | 1,625,000 | 1,944,000 | 2,118,000 | 1,587,000 | 1,524,000 | 1,814,000 | 2,612,000 | 3,415,000 | 3,416,000 | 3,635,000 | 2,907,000 | 2,518,000 | 2,764,000 | 3,243,000 | 3,104,000 | 3,404,000 | 3,392,000 | 3,911,000 | 3,500,000 | 2,030,000 | 1,797,000 | 1,309,000 | 819,000 |
depreciation and amortization expense | 395,000 | 467,000 | 376,000 | 386,000 | 407,000 | ||||||||||||||||||||||||||||
non-cash lease expense | 623,000 | 611,000 | 598,000 | 587,000 | 575,000 | 565,000 | 585,000 | ||||||||||||||||||||||||||
change in fair value of derivative liabilities | 1,650,000 | 2,650,000 | 850,000 | 900,000 | 1,650,000 | ||||||||||||||||||||||||||||
other | 0 | -294,000 | 77,000 | -22,000 | 2,000 | 4,000 | -89,000 | -5,000 | |||||||||||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||
prepaid expenses and other assets | 954,000 | -7,649,000 | 1,716,000 | -4,083,000 | 2,023,000 | -993,000 | -219,000 | -1,337,000 | |||||||||||||||||||||||||
accounts payable | 2,321,000 | -5,257,000 | 3,697,000 | 6,000 | 461,000 | 815,000 | 918,000 | 1,068,000 | -596,000 | 134,000 | -929,000 | -2,714,000 | 2,745,000 | -5,906,000 | 287,000 | 302,000 | 71,000 | 570,000 | 957,000 | -228,000 | -90,000 | -829,000 | 1,290,000 | 417,000 | -4,309,000 | 3,771,000 | -2,429,000 | 771,000 | 1,666,000 | -1,503,000 | 950,000 | -703,000 | -354,000 |
change in operating lease liability | -496,000 | ||||||||||||||||||||||||||||||||
accrued expenses and other liabilities | -473,000 | 152,000 | 2,203,000 | 1,970,000 | -275,000 | 3,309,000 | 93,000 | -260,000 | |||||||||||||||||||||||||
net cash from operating activities | -47,230,000 | -53,555,000 | -33,472,000 | -37,412,000 | -31,850,000 | -29,645,000 | -23,708,000 | -21,467,000 | -25,192,000 | -20,823,000 | -17,897,000 | -27,465,000 | -27,995,000 | -34,480,000 | -20,429,000 | -15,878,000 | -27,190,000 | -20,874,000 | -18,424,000 | -17,100,000 | -21,366,000 | 1,307,000 | -15,564,000 | -13,068,000 | -29,274,000 | -21,245,000 | -19,241,000 | -26,301,000 | -25,927,000 | -21,404,000 | -15,290,000 | -16,331,000 | -17,172,000 |
capital expenditures | -165,000 | -565,000 | -85,000 | -377,000 | -126,000 | -204,000 | -15,000 | -286,000 | -149,000 | -90,000 | -383,000 | -536,000 | -506,000 | -856,000 | -839,000 | -1,136,000 | -184,000 | -660,000 | -237,000 | -349,000 | -35,000 | -60,000 | -80,000 | -78,000 | -681,000 | -645,000 | -650,000 | -1,139,000 | -1,953,000 | -1,437,000 | -2,122,000 | -3,216,000 | -1,001,000 |
free cash flows | -47,395,000 | -54,120,000 | -33,557,000 | -37,789,000 | -31,976,000 | -29,849,000 | -23,723,000 | -21,753,000 | -25,341,000 | -20,913,000 | -18,280,000 | -28,001,000 | -28,501,000 | -35,336,000 | -21,268,000 | -17,014,000 | -27,374,000 | -21,534,000 | -18,661,000 | -17,449,000 | -21,401,000 | 1,247,000 | -15,644,000 | -13,146,000 | -29,955,000 | -21,890,000 | -19,891,000 | -27,440,000 | -27,880,000 | -22,841,000 | -17,412,000 | -19,547,000 | -18,173,000 |
cash flows from investing activities: | |||||||||||||||||||||||||||||||||
purchases of property and equipment | -165,000 | -565,000 | -85,000 | -377,000 | -126,000 | -204,000 | -15,000 | -286,000 | -149,000 | -90,000 | -383,000 | -536,000 | -506,000 | -856,000 | -839,000 | -1,136,000 | -184,000 | -660,000 | -237,000 | -349,000 | -35,000 | -60,000 | -80,000 | -78,000 | -681,000 | -645,000 | -650,000 | -1,139,000 | -1,953,000 | -1,437,000 | -2,122,000 | -3,216,000 | -1,001,000 |
proceeds from maturities of available-for-sale securities | 128,380,000 | 38,000,000 | 31,000,000 | 38,000,000 | 74,500,000 | 15,300,000 | 45,000,000 | ||||||||||||||||||||||||||
purchases of available-for-sale securities | -83,457,000 | -23,921,000 | -83,188,000 | -63,440,000 | -65,337,000 | -15,329,000 | -85,472,000 | -20,190,000 | -83,346,000 | -14,614,000 | -34,252,000 | -19,612,000 | -50,462,000 | -103,807,000 | -8,881,000 | -16,678,000 | -76,203,000 | 0 | 0 | 0 | -8,937,000 | -7,143,000 | -15,416,000 | -5,420,000 | -4,205,000 | -9,119,000 | |||||||
net cash from investing activities | 44,758,000 | 47,014,000 | -45,273,000 | -32,732,000 | -27,463,000 | 38,567,000 | -10,987,000 | -5,176,000 | -38,490,000 | 45,296,000 | -24,635,000 | 66,100,000 | 14,909,000 | -59,595,000 | 37,743,000 | 30,176,000 | -72,510,000 | -48,717,000 | -35,000 | -60,000 | -80,000 | 322,000 | 6,418,000 | 2,855,000 | 3,963,000 | 24,143,000 | -6,445,000 | -21,264,000 | -1,397,000 | -2,490,000 | -1,611,000 | ||
cash flows from financing activities: | |||||||||||||||||||||||||||||||||
proceeds from issuance of common stock and pre-funded warrants in public offering, net of underwriting discounts and commissions | 0 | 0 | 0 | 189,637,000 | |||||||||||||||||||||||||||||
payments of common stock and pre-funded warrants issuance costs in public offering | 0 | 0 | -1,661,000 | -20,000 | |||||||||||||||||||||||||||||
proceeds from issuance of common stock and pre-funded warrants in private placement | 239,972,000 | 0 | 0 | -1,000 | 108,859,000 | ||||||||||||||||||||||||||||
payments of common stock and pre-funded warrants issuance costs in private placement | -12,890,000 | 0 | 0 | ||||||||||||||||||||||||||||||
proceeds from issuance of common stock in at-the-market public offering, net of sales commissions | 11,927,000 | 5,117,000 | 1,419,000 | 0 | 246,000 | ||||||||||||||||||||||||||||
proceeds from exercises of common stock options | 18,000 | 0 | 0 | 278,000 | 9,000 | 151,000 | |||||||||||||||||||||||||||
payments of principal portion of finance lease obligations | -203,000 | -243,000 | -142,000 | -135,000 | -128,000 | -120,000 | |||||||||||||||||||||||||||
net cash from financing activities | 239,027,000 | 5,143,000 | 1,176,000 | -1,601,000 | 189,728,000 | 6,940,000 | 3,256,000 | 5,000,000 | 107,241,000 | 505,000 | 0 | 74,737,000 | -1,000 | 73,000 | 22,000 | 66,000 | 3,000 | -238,000 | 135,154,000 | -287,000 | -13,000 | 0 | -193,000 | 131,713,000 | |||||||||
net increase in cash, cash equivalents, and restricted cash | 236,555,000 | -71,745,000 | 130,415,000 | -21,643,000 | 43,559,000 | ||||||||||||||||||||||||||||
cash, cash equivalents, and restricted cash at beginning of period | 61,890,000 | 0 | 0 | 0 | 82,187,000 | 0 | 0 | 0 | 75,848,000 | 0 | 0 | 0 | 157,217,000 | 0 | 0 | 0 | 121,206,000 | 0 | 0 | 0 | 155,071,000 | 0 | 0 | 0 | 76,370,000 | 0 | 0 | 0 | 86,693,000 | 0 | 0 | ||
cash, cash equivalents, and restricted cash at end of period | 298,445,000 | -1,398,000 | -77,569,000 | -71,745,000 | 212,602,000 | 15,862,000 | -31,439,000 | -21,643,000 | 119,407,000 | 24,978,000 | -42,532,000 | -73,080,000 | 166,482,000 | 106,357,000 | -5,521,000 | -75,400,000 | 131,781,000 | 9,368,000 | -90,931,000 | -66,055,000 | 268,824,000 | 129,947,000 | -15,644,000 | -12,746,000 | 53,514,000 | -18,677,000 | 42,884,000 | -2,158,000 | 54,321,000 | -42,681,000 | -16,687,000 | -19,014,000 | 165,075,000 |
non-cash acquired in-process research and development | 0 | ||||||||||||||||||||||||||||||||
common stock issued as upfront payment for collaboration and license agreement | |||||||||||||||||||||||||||||||||
proceeds from sale of property and equipment | 0 | ||||||||||||||||||||||||||||||||
proceeds from sales and maturities of available-for-sale securities | |||||||||||||||||||||||||||||||||
employee stock purchase plan purchases | 229,000 | 0 | 192,000 | 0 | |||||||||||||||||||||||||||||
net increase in cash, cash equivalents and restricted cash | 9,265,000 | 106,357,000 | -5,521,000 | -75,400,000 | 10,575,000 | -66,055,000 | 113,753,000 | 129,947,000 | -18,677,000 | 42,884,000 | -2,158,000 | -32,372,000 | -42,681,000 | -16,687,000 | -19,014,000 | 112,930,000 | |||||||||||||||||
operating lease liabilities | -443,000 | -432,000 | -416,000 | -398,000 | |||||||||||||||||||||||||||||
net decrease in cash, cash equivalents, and restricted cash | |||||||||||||||||||||||||||||||||
operating activities: | |||||||||||||||||||||||||||||||||
net amortization of discount on available-for-sale securities | |||||||||||||||||||||||||||||||||
common stock issued as up-front payment for collaboration and license agreement | |||||||||||||||||||||||||||||||||
prepaid expenses and other current and non-current assets | 124,000 | 2,350,000 | -299,000 | 1,261,000 | 394,000 | 2,715,000 | 3,952,000 | -3,366,000 | -7,608,000 | -2,260,000 | 1,390,000 | -769,000 | -1,420,000 | 1,088,000 | 1,567,000 | -1,205,000 | 3,195,000 | -3,594,000 | -707,000 | -1,348,000 | 217,000 | -641,000 | |||||||||||
accrued expenses and other current and non-current liabilities | -2,119,000 | 433,000 | -2,412,000 | -4,911,000 | 2,569,000 | -4,966,000 | 8,674,000 | -445,000 | 2,576,000 | -302,000 | -613,000 | -3,916,000 | 887,000 | -226,000 | -643,000 | -1,175,000 | 5,101,000 | -1,435,000 | -1,252,000 | 990,000 | 546,000 | -1,351,000 | |||||||||||
investing activities: | |||||||||||||||||||||||||||||||||
financing activities: | |||||||||||||||||||||||||||||||||
proceeds from issuance of common stock in public offering, net of sales commissions | 6,857,000 | 3,098,000 | 5,358,000 | 3,056,000 | |||||||||||||||||||||||||||||
proceeds from exercise of stock options | 3,000 | 9,000 | 29,000 | ||||||||||||||||||||||||||||||
depreciation, impairment, and amortization expense | 405,000 | 1,235,000 | 327,000 | ||||||||||||||||||||||||||||||
supplemental disclosure of cash flow information: | |||||||||||||||||||||||||||||||||
cash paid for interest | -82,000 | ||||||||||||||||||||||||||||||||
supplemental disclosure of non-cash investing and operating activities: | |||||||||||||||||||||||||||||||||
right-of-use assets acquired through operating leases | 0 | -10,000 | 417,000 | ||||||||||||||||||||||||||||||
decrease in right-of-use assets due to lease termination | -64,000 | 0 | -197,000 | ||||||||||||||||||||||||||||||
decrease in property and equipment due to asset exchange | |||||||||||||||||||||||||||||||||
property and equipment purchases included in accounts payable and accrued expenses | 16,000 | 0 | 20,000 | ||||||||||||||||||||||||||||||
gain on termination of lease | -89,000 | 0 | |||||||||||||||||||||||||||||||
payments of common stock issuance costs | -4,825,000 | ||||||||||||||||||||||||||||||||
supplemental disclosure of non-cash investing and financing activities: | |||||||||||||||||||||||||||||||||
net amortization of (discount)/premium on available-for-sale securities | |||||||||||||||||||||||||||||||||
loss on sale of property and equipment | 0 | 7,000 | -9,000 | ||||||||||||||||||||||||||||||
gain on lease termination | |||||||||||||||||||||||||||||||||
gain on acquisition | |||||||||||||||||||||||||||||||||
accounts receivable - related party | 0 | 0 | 14,000 | 96,000 | 484,000 | -308,000 | -6,000 | -280,000 | |||||||||||||||||||||||||
deferred revenue - related party, current and non-current | |||||||||||||||||||||||||||||||||
acquisition of business, net of cash received | |||||||||||||||||||||||||||||||||
proceeds from issuance of common stock, net of issuance costs | 435,000 | 0 | 0 | ||||||||||||||||||||||||||||||
proceeds from financing liabilities | |||||||||||||||||||||||||||||||||
proceeds from exercise of pre-funded warrants | |||||||||||||||||||||||||||||||||
employee stock purchases and withholdings | |||||||||||||||||||||||||||||||||
repayment of financing liabilities | |||||||||||||||||||||||||||||||||
issuance of common stock in acquisition | |||||||||||||||||||||||||||||||||
right-of-use assets obtained in exchange for operating lease liabilities | -18,000 | 11,000 | 0 | 0 | |||||||||||||||||||||||||||||
decrease in right-of-use asset and lease liability due to lease termination | |||||||||||||||||||||||||||||||||
decrease in property, plant and equipment due to asset exchange | |||||||||||||||||||||||||||||||||
property and equipment included in accounts payable and accruals | 310,000 | -383,000 | 336,000 | 264,000 | -241,000 | 298,000 | 37,000 | 10,000 | -28,000 | 55,000 | 439,000 | -344,000 | -648,000 | 1,043,000 | 439,000 | -202,000 | |||||||||||||||||
amortization of (discount) premium on available-for-sale securities | -984,000 | -58,000 | -215,000 | ||||||||||||||||||||||||||||||
depreciation and impairment expense | 588,000 | 703,000 | 1,077,000 | ||||||||||||||||||||||||||||||
deferred revenue- related party, current and non-current | 0 | -6,170,000 | -1,910,000 | -3,229,000 | -3,309,000 | -3,055,000 | |||||||||||||||||||||||||||
proceeds from the sale of property and equipment | |||||||||||||||||||||||||||||||||
proceeds from sale and maturities of available-for-sale securities | 10,000,000 | 20,866,000 | 37,766,000 | 65,610,000 | 45,348,000 | 46,808,000 | 0 | 400,000 | 7,500,000 | 13,550,000 | 32,425,000 | 10,924,000 | 6,145,000 | 4,931,000 | 8,509,000 | ||||||||||||||||||
proceeds from exercise of warrants | 0 | 0 | 22,000 | ||||||||||||||||||||||||||||||
employee stock purchases and withholding | 0 | -1,000 | |||||||||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -42,532,000 | -12,746,000 | -22,856,000 | ||||||||||||||||||||||||||||||
decrease in right-of-use asset due to lease termination | 0 | 0 | |||||||||||||||||||||||||||||||
decrease in property plant and equipment due to asset exchange | 0 | ||||||||||||||||||||||||||||||||
net cash provided in investing activities | 37,260,000 | ||||||||||||||||||||||||||||||||
net amortization of premium/(discount) on available-for-sale securities | |||||||||||||||||||||||||||||||||
proceeds from the issuance of common stock to a related party in connection with the stock purchase agreement | |||||||||||||||||||||||||||||||||
payment of offering costs | -287,000 | ||||||||||||||||||||||||||||||||
proceeds for exercise of stock options | |||||||||||||||||||||||||||||||||
decrease in right-of-use assets and lease liability due to lease termination | |||||||||||||||||||||||||||||||||
amortization of premium on available-for-sale securities | -17,000 | 155,000 | 371,000 | 5,000 | |||||||||||||||||||||||||||||
depreciation expense | 438,000 | 722,000 | 709,000 | 751,000 | 719,000 | 734,000 | 796,000 | 766,000 | 1,334,000 | 1,026,000 | 806,000 | 764,000 | 658,000 | 596,000 | 481,000 | 545,000 | 313,000 | 227,000 | |||||||||||||||
loss on disposal of property and equipment | |||||||||||||||||||||||||||||||||
offering costs in accruals | 247,000 | ||||||||||||||||||||||||||||||||
proceeds from issuance of pre-funded warrants | |||||||||||||||||||||||||||||||||
decrease in rou asset and lease liability due to lease termination | |||||||||||||||||||||||||||||||||
amortization of (discount)/premium on available-for-sale securities | 528,000 | 0 | 0 | 1,000 | -21,000 | -33,000 | -11,000 | -87,000 | -148,000 | -38,000 | -18,000 | ||||||||||||||||||||||
gain on disposal of property and equipment | 6,000 | 0 | 3,000 | ||||||||||||||||||||||||||||||
change in unrealized loss | -11,000 | ||||||||||||||||||||||||||||||||
decrease in right of use asset due to lease termination | 0 | ||||||||||||||||||||||||||||||||
proceeds from issuance of common stock | -247,000 | 135,125,000 | 0 | ||||||||||||||||||||||||||||||
proceeds from landlord lease incentive for tenant improvements | 0 | ||||||||||||||||||||||||||||||||
proceeds from initial public offering of common stock, net of commissions and underwriting discounts | 0 | 0 | 0 | 133,688,000 | |||||||||||||||||||||||||||||
principal payments under capital lease obligation | |||||||||||||||||||||||||||||||||
conversion of series a, b, c and d common units into shares of common stock | 0 | 0 | 0 | 65,180,000 | |||||||||||||||||||||||||||||
conversion of series 2 senior preferred units into shares of common stock | 0 | 0 | 0 | 55,002,000 | |||||||||||||||||||||||||||||
conversion of series 1 senior preferred units into shares of common stock | 0 | 0 | 0 | 25,000,000 | |||||||||||||||||||||||||||||
conversion of junior preferred units into shares of common stock | 0 | 0 | 0 | 44,177,000 | |||||||||||||||||||||||||||||
property and equipment acquired through a capital lease | |||||||||||||||||||||||||||||||||
proceeds from issuance of warrants | |||||||||||||||||||||||||||||||||
operating lease liabilities arising from obtaining right-of-use asset | 0 | 0 | 1,629,000 | ||||||||||||||||||||||||||||||
offering costs included in accounts payable and accruals | |||||||||||||||||||||||||||||||||
purchases of marketable investments | -401,000 | ||||||||||||||||||||||||||||||||
(gain) from revaluation of preferred unit tranche right | |||||||||||||||||||||||||||||||||
prepaid expenses and other current assets | |||||||||||||||||||||||||||||||||
accrued expenses and other current liabilities | |||||||||||||||||||||||||||||||||
proceeds from issuance of series 1 senior preferred units | |||||||||||||||||||||||||||||||||
proceeds from issuance of series 2 senior preferred units | |||||||||||||||||||||||||||||||||
accretion to redemption value for redeemable preferred units | |||||||||||||||||||||||||||||||||
redemption of preferred units | |||||||||||||||||||||||||||||||||
redemption of redeemable interest from non-controlling interest in solid gt | |||||||||||||||||||||||||||||||||
deferred offering costs included in accounts payable and accrued expenses | |||||||||||||||||||||||||||||||||
issuance of series d common units in exchange for series a common units | |||||||||||||||||||||||||||||||||
issuance of series a common units in exchange for redeemable preferred units | |||||||||||||||||||||||||||||||||
issuance of junior preferred units upon redemption of class d non-controlling interest in solid gt | |||||||||||||||||||||||||||||||||
issuance of series c common units in exchange for class b non-controlling interest in solid gt | |||||||||||||||||||||||||||||||||
issuance of series d common units in exchange for class c non-controlling interest in solid gt | |||||||||||||||||||||||||||||||||
payment of deferred offering costs | 0 | 0 | -193,000 | -1,975,000 | |||||||||||||||||||||||||||||
deferred offering costs included in accounts payable | 193,000 | ||||||||||||||||||||||||||||||||
loss from revaluation of preferred unit tranche right | |||||||||||||||||||||||||||||||||
proceeds from sales and maturities of available for sale securities | |||||||||||||||||||||||||||||||||
purchases of available for sale securities | |||||||||||||||||||||||||||||||||
proceeds from issuance of redeemable preferred units | |||||||||||||||||||||||||||||||||
reclassification of preferred unit tranche liability to preferred units upon settlement | |||||||||||||||||||||||||||||||||
decretion (accretion) to redemption value for redeemable preferred units | |||||||||||||||||||||||||||||||||
revaluation of tranche liability | |||||||||||||||||||||||||||||||||
deferred offering costs included in accounts payable and accruals | |||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of period | 52,145,000 | ||||||||||||||||||||||||||||||||
offering costs included in accounts payable | |||||||||||||||||||||||||||||||||
property and equipment included in accounts payable | 1,479,000 | ||||||||||||||||||||||||||||||||
amortization of premium on available for sale securities | |||||||||||||||||||||||||||||||||
changes in restricted cash | |||||||||||||||||||||||||||||||||
proceeds from issuance of non-controlling interest in solid gt | |||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | |||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | |||||||||||||||||||||||||||||||||
cash and cash equivalents at end of period |